Role of neutrophils in BCG immunotherapy for bladder cancer. - Wikidata - wikimedia - TriplyDB

Role of neutrophils in BCG immunotherapy for bladder cancer.

Role of neutrophils in BCG immunotherapy for bladder cancer.

http://www.wikidata.org/entity/Q36803793

about

Mining of vaccine-associated IFN-γ gene interaction networks using the Vaccine Ontology Cell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomena Oxidative stress sensitizes bladder cancer cells to TRAIL mediated apoptosis by down-regulating anti-apoptotic proteins Bacteriolytic therapy of experimental pancreatic carcinoma.Immunotherapy for bladder cancer.The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system.Role of Rip2 in development of tumor-infiltrating MDSCs and bladder cancer metastasis.Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guérin and prospective use in immunotherapy of bladder cancer.Mathematical model of tumor immunotherapy for bladder carcinoma identifies the limitations of the innate immune response Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL.Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier.Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma.HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer Immunological basis in the pathogenesis and treatment of bladder cancer Nonmuscle invasive bladder cancer: a primer on immunotherapy.Immunotherapy for urothelial carcinoma: current status and perspectives.Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapy.Intravesical Toll-like receptor 7 agonist R-837: optimization of its formulation in an orthotopic mouse model of bladder cancer.Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.Combination of BCG and interferon intravesical immunotherapy: an update.Emerging apoptosis agonists for bladder cancer.Predicting response to bacillus Calmette-Guérin (BCG) in patients with carcinoma in situ of the bladder Polymorphonuclear neutrophils and cancer: intense and sustained neutrophilia as a treatment against solid tumors.Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.Should intravesical Bacillus Calmette-Guérin be employed in transplant recipients with bladder carcinoma?Unravelling the complexity of cancer-immune system interplay.Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer.Toll-like receptor modulators: a patent review (2006-2010).Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.Toll-like receptors in urothelial cells--targets for cancer immunotherapy.From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa.The BCG replacement vaccine VPM1002: from drawing board to clinical trial.Lipopolysacchride-treated mammary carcinomas secrete proinflammatory chemokines and exhibit reduced growth rates in vivo, but not in vitro.Tumor-endothelium cross talk blocks recruitment of neutrophils to endothelial cells: a novel mechanism of endothelial cell anergy.Revisiting the role of T cells in tumor regression.Insights on distinct pathways of thiazolidinediones (PPARgamma ligand)-promoted apoptosis in TRAIL-sensitive or -resistant malignant urothelial cells.Implication of 4E-BP1 protein dephosphorylation and accumulation in pancreatic cancer cell death induced by combined gemcitabine and TRAIL.Tumor-associated neutrophils suppress pro-tumoral IL-17+ γδ T cells through induction of oxidative stress.

P2860

Q21198686-BE2C7CF7-20EA-4DA1-B055-C41F062F30EA Q26860953-E1D968AE-93D1-40E9-8CBB-71C7D7E33C7C Q33485621-B41FD29B-1DAC-47E5-8EC2-9807A9970CDB Q34018256-A07D4E3F-CA9C-4466-ACB5-BEAABD3D963F Q34477444-FA125BF2-1B57-40C2-8258-149837271C84 Q35018021-5C83865B-3496-4DCE-B630-B103EC7BC20A Q35147988-25327F10-FACD-4F2A-A1D7-9A54B5921457 Q35215350-90550174-804D-4776-B4B0-DADBB2286EFD Q36038379-27D404AF-D612-43AD-A5E3-9A943A43C3CD Q36056007-3B8AF142-3225-4DCA-AE52-B5033AB31F8F Q36070462-FBACD987-BEB1-4424-98A1-FBD1BFD6F65C Q36075245-74ADF604-F6D3-480F-AD6F-E7D25EB996A5 Q36109585-997BD0D2-B1CE-4993-A52B-B46C152FDB9B Q36127825-1D5A8654-B5CA-4CEF-8865-67DE6BA61AFB Q36260118-18F648FE-B556-4B1E-88AA-8BE2F5AF6CB7 Q37094072-3AC1E200-59B5-4B9C-8A34-AC8781871078 Q37137381-42EDC08F-732F-4944-839B-397BFCC6172C Q37389360-7C094D70-E387-483E-9218-850BA9C33F55 Q37423131-1850363B-754B-4194-B2FB-CD64D6A95E28 Q37457553-1FB54623-B486-4720-BFC9-2C3DD36E1EC3 Q37500031-DAB13E1A-D05F-49BD-B088-A827F8FA7FD2 Q37601481-A218B793-64A8-4AD7-A45A-E6FDA19C750D Q37635650-6C6ECC1D-7439-4C3F-A9DD-8A1994AF0B96 Q37646545-FF52ED67-92A6-422E-B2D5-6ECC4AC3660E Q37655607-255F6EF2-4688-4BDA-9F23-29D7D9B75058 Q37735941-1DB40B02-46D4-499A-8C9C-80D358E531CE Q37765590-89DA4687-BF6F-4548-B825-5C0774D91234 Q37773294-B1CE01A1-AD62-4F16-BFCB-C83C6F7FD0EC Q37853197-8BE4CFEC-E0C5-4168-BAF4-F3307B626665 Q38039958-E92AA039-E250-438B-8A1D-9E208256DF71 Q38131726-08108D40-14ED-47BA-B735-7C824E1D26B3 Q38142595-E11E398A-504A-405F-9540-B4088AF0F143 Q38202181-409B7D7C-CDC0-4F3A-AB79-40683E0B25D8 Q39783021-B9940EE3-ADC0-4A82-836F-FB3C5E7FD67A Q39793034-C484B027-16B5-48D8-90C9-2EE9D8709837 Q42214180-1B735D38-9AB7-453E-B775-956CE672F5BA Q43184836-541480D8-F605-44F5-B277-0F1C3925C647 Q47300891-267CF3B0-B2AE-4540-B70C-FC13C0DF9D0F Q55044228-093645C4-EE29-4C84-8A13-DD508708BD78

P2860

Role of neutrophils in BCG immunotherapy for bladder cancer.

http://www.wikidata.org/entity/Q36803793

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Role of neutrophils in BCG immunotherapy for bladder cancer.

@ast

Role of neutrophils in BCG immunotherapy for bladder cancer.

@en

type

label

Role of neutrophils in BCG immunotherapy for bladder cancer.

@ast

Role of neutrophils in BCG immunotherapy for bladder cancer.

@en

prefLabel

Role of neutrophils in BCG immunotherapy for bladder cancer.

@ast

Role of neutrophils in BCG immunotherapy for bladder cancer.

@en

P1433

Q36803793-CE35CF99-0022-474F-9503-A2E1540423F4

P1476

Q36803793-59EA80D4-8CBA-4B44-BD7C-457C28C420F9

P2093

Q36803793-0A417BA9-A7FC-4004-B108-8BBA097850D0

Q36803793-5F9D32D4-FA5B-48F0-9ADD-6FD43992B3C5

Q36803793-88DE2952-23CE-488F-BDAD-A28BBA34881D

P2860

Q36803793-060CE39A-8C6C-4576-A80F-53E8E406DF5F

Q36803793-143481B6-7BCE-43F9-AE19-35A84472DE35

Q36803793-20259ED7-7A03-453E-B760-315F6056D91F

Q36803793-260AC439-C657-414C-8B95-933D785EE7D4

Q36803793-3000F421-22F2-445F-80F5-ABBB7E23F654

Q36803793-3FF4391B-E2D4-479C-A80B-E0534EEE70E5

Q36803793-48FA1A12-C62E-4E18-AAB4-E98FD89A6EB7

Q36803793-4E989FF5-E0BB-4966-A881-9E642E25B389

Q36803793-6857F7E5-50C9-4B3B-BA5B-6AB34E81BB1D

Q36803793-686B84CE-F6F7-4A85-BF21-DB4FED57C10C

P304

Q36803793-CCD6E8E3-C781-4580-AE18-5D614CB8C822

P31

Q36803793-5C1CC773-6787-468A-BC30-080C9F0DA9B0

P356

Q36803793-E1AD539E-438A-4686-BE44-96533C5FDBA1

P433

Q36803793-72115A8A-89AE-4311-9590-9D25FE04818F

P478

Q36803793-8D912744-C7BF-42B1-BAA4-79EDEF2CA905

P577

Q36803793-2EDEE0CB-193E-4670-8ACC-83FFA84C59AC

P5875

Q36803793-66BE2080-B560-48E7-B073-18D355D4B606

P698

Q36803793-31ADA2F7-974F-4D49-8D0C-32DCAAA04535

P921

Q36803793-3EF1BEAB-2DE7-45A1-9971-240D85153C1A

P932

Q36803793-5A751293-FEB7-4E12-A18B-B9BD2FDE097E

P356

J.UROLONC.2007.11.031

P1433

Urologic Oncology

P1476

Role of neutrophils in BCG immunotherapy for bladder cancer.

@en

P2093

Mark P Simons

http://www.w3.org/2001/XMLSchema#string

Michael A O'Donnell

http://www.w3.org/2001/XMLSchema#string

Thomas S Griffith

http://www.w3.org/2001/XMLSchema#string

P2860

Neutrophil granules and secretory vesicles in inflammation

Cancer statistics, 2004

BCG immunotherapy of bladder cancer: 20 years on.

Urinary cytokines reflecting the immunological response in the urinary bladder to biological response modifiers: their practical use.

Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response

IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells.

Therapeutic potential of mycobacterial cell wall-DNA complexes.

A novel method for monitoring Mycobacterium bovis BCG trafficking with recombinant BCG expressing green fluorescent protein.

Role of epithelial interleukin-8 (IL-8) and neutrophil IL-8 receptor A in Escherichia coli-induced transuroepithelial neutrophil migration.

Identification of the mycobacterial subcomponents involved in the release of tumor necrosis factor-related apoptosis-inducing ligand from human neutrophils

P304

341-345

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.UROLONC.2007.11.031

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5259050

http://www.w3.org/2001/XMLSchema#string

P698

18593617

http://www.w3.org/2001/XMLSchema#string

P921

P932

2493065

http://www.w3.org/2001/XMLSchema#string